78.08

1.35% -1.07

Genedx Holdings Corp (WGS)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Genedx Holdings Corp stock is traded at $78.08, with a volume of 391.85K. It is down -1.35% in the last 24 hours and up +25.07% over the past month. GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Previous Close:

$79.15

Open:

$78.68

24h Volume:

391.85K

Relative Volume:

0.39

Market Cap:

$2.33B

Revenue:

$442.68M

Net Income/Loss:

$-77.81M

P/E Ratio:

-29.26

EPS:

-2.6684

Net Cash Flow:

$-28.65M

1W Performance:

+1.30%

1M Performance:

+25.07%

6M Performance:

-13.39%

1Y Performance:

-36.46%

1-Day Range:

$76.98

$79.37

1-Week Range:

$75.58

$83.87

52-Week Range:

$32.21

$170.87

Genedx Holdings Corp Stock (WGS) Company Profile

Name

Genedx Holdings Corp

Sector

Healthcare (1080)

Industry

Diagnostics & Research (50)

Phone

888-729-1206

Address

333 LUDLOW STREET, STAMFORD

Employee

1,300

Twitter

Next Earnings Date

2026-08-03

Latest SEC Filings

WGS's Discussions on Twitter

Compare WGS vs TMO, DHR, NTRA, IDXX, A

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
WGS Genedx Holdings Corp	78.08	2.46B	442.68M	-77.81M	-28.65M	-2.6684
TMO Thermo Fisher Scientific Inc	588.29	222.96B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	202.45	144.67B	24.78B	3.68B	5.29B	5.1743
NTRA Natera Inc	309.93	45.54B	2.50B	-226.32M	71.51M	-1.6412
IDXX Idexx Laboratories Inc	550.96	44.95B	4.45B	1.10B	1.06B	13.59
A Agilent Technologies Inc	148.53	41.87B	7.23B	1.41B	1.09B	4.979

Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-09-26	Upgrade	Wells Fargo	Equal Weight → Overweight
Oct-20-25	Initiated	Canaccord Genuity	Buy
Jul-09-25	Initiated	Piper Sandler	Overweight
May-15-25	Initiated	Guggenheim	Buy
May-09-25	Upgrade	Jefferies	Hold → Buy
Aug-28-24	Initiated	Wells Fargo	Equal Weight
Jul-10-24	Initiated	Craig Hallum	Buy
Jun-03-24	Resumed	Jefferies	Hold

View All

Genedx Holdings Corp Stock (WGS) Latest News

Aug 14, 2026

Precision Trading with Genedx Holdings Corp. (WGS) Risk Zones - Stock Traders Daily

Aug 14, 2026

The Manufacturers Life Insurance Company Sells 12,820 Shares of GeneDx Holdings Corp. $WGS - MarketBeat

Aug 14, 2026

Aug 13, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Stockholders to Connect - ACCESS Newswire

Aug 13, 2026

Sei Investments Co. Trims Stock Position in GeneDx Holdings Corp. $WGS - MarketBeat

Aug 13, 2026

Aug 11, 2026

WGS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce - The National Law Review

Aug 11, 2026

Is GeneDx Holdings Corp (WGS) Overvalued After 5.1% Rally? GF Va - GuruFocus

Aug 11, 2026